KR900700130A - 종양전이의 면역요법용, 바이러스 변성 종양 백신과 그의 제조방법 - Google Patents
종양전이의 면역요법용, 바이러스 변성 종양 백신과 그의 제조방법Info
- Publication number
- KR900700130A KR900700130A KR1019890702004A KR890702004A KR900700130A KR 900700130 A KR900700130 A KR 900700130A KR 1019890702004 A KR1019890702004 A KR 1019890702004A KR 890702004 A KR890702004 A KR 890702004A KR 900700130 A KR900700130 A KR 900700130A
- Authority
- KR
- South Korea
- Prior art keywords
- vaccine
- tumor
- virus
- immunotherapy
- state
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18133—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3806565A DE3806565A1 (de) | 1988-03-01 | 1988-03-01 | Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen |
| DEP3806565.7 | 1988-03-01 | ||
| PCT/EP1989/000186 WO1989007946A1 (fr) | 1988-03-01 | 1989-02-27 | Vaccins tumoraux modifies viralement pour immunotherapie de metastases tumorales |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR900700130A true KR900700130A (ko) | 1990-08-11 |
Family
ID=6348527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019890702004A Withdrawn KR900700130A (ko) | 1988-03-01 | 1989-02-27 | 종양전이의 면역요법용, 바이러스 변성 종양 백신과 그의 제조방법 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5273745A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0331102B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPH02504034A (cg-RX-API-DMAC7.html) |
| KR (1) | KR900700130A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE90877T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU3188989A (cg-RX-API-DMAC7.html) |
| DE (2) | DE3806565A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK541889D0 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2042828T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1989007946A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3922444A1 (de) * | 1988-03-01 | 1991-01-10 | Deutsches Krebsforsch | Virusmodifizierte tumorvakzine fuer die immuntherapie von tumormetastasen |
| DE4204132C2 (de) * | 1991-02-12 | 1997-12-18 | Rudolf Dr Pekar | Aufbereitung für die Gewinnung von Vakzinen für eine Immuntherapie |
| ATE230615T1 (de) * | 1991-10-04 | 2003-01-15 | Whitehead Biomedical Inst | Regulierung der systemischen immunantworten mittels zytokinen und antigenen |
| ES2310580T3 (es) | 1993-04-30 | 2009-01-16 | Wellstat Biologics Corporation | Composiciones purificadas del virus de la enfermedad de newcastle. |
| DE19506483A1 (de) * | 1995-02-24 | 1996-08-29 | Jens Dr Dr Atzpodien | Lyophilisat-Vakzine |
| US6406689B1 (en) | 1995-10-03 | 2002-06-18 | Frank W. Falkenberg | Compositions and methods for treatment of tumors and metastatic diseases |
| EP0805207A1 (en) * | 1996-05-02 | 1997-11-05 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Polycistronic expression plasmid for tumor rejection |
| EP0951475B1 (en) * | 1996-05-03 | 2003-07-16 | Thomas Jefferson University | Metastatic colorectal cancer vaccine |
| NZ330995A (en) * | 1996-10-04 | 2000-12-22 | Univ Jefferson | Generation of T cells mediating an immune response and use for treating cancer |
| DE69731950T2 (de) * | 1997-08-22 | 2005-05-19 | Science Park Raf S.P.A. | Tumorvakzinierung mittels Verwendung autologer oder HLA-verwandter Antigen präsentierender Zellen (APC), die mit einem Tumorantigen sowie einem eine Immunantwort hervorrufenden Fremdantigen transduziert sind |
| TW575420B (en) * | 1997-09-22 | 2004-02-11 | Kirin Brewery | Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides |
| US7470426B1 (en) | 1997-10-09 | 2008-12-30 | Wellstat Biologics Corporation | Treatment of neoplasms with viruses |
| US7780962B2 (en) * | 1997-10-09 | 2010-08-24 | Wellstat Biologics Corporation | Treatment of neoplasms with RNA viruses |
| US20030044384A1 (en) * | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| CN1477964A (zh) * | 1999-04-15 | 2004-02-25 | 应用病毒治疗肿瘤 | |
| US8147822B1 (en) | 1999-09-17 | 2012-04-03 | Wellstat Biologics Corporation | Oncolytic virus |
| EP1092439A1 (en) * | 1999-10-13 | 2001-04-18 | Thorsten Dr. Ahlert | Activation of antigen-specific T cells by virus/antigen-treated dendritic cells |
| RU2172182C1 (ru) * | 2000-07-27 | 2001-08-20 | Бритов Василий Александрович | Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления |
| WO2004096244A1 (en) * | 2003-05-02 | 2004-11-11 | Md Bioalpha Co. Ltd. | Method of preparing tumor vaccine for the inducement of anti-tumor activity and a pharmaceutical composition containing the same |
| JP5603012B2 (ja) | 2005-12-02 | 2014-10-08 | トヘ モウント シナイ スクール オフ メディシネ オフ ニューヨーク ウニベルシトイ | 非天然表面タンパク質を提示するキメラウイルス及びその使用 |
| US9283266B2 (en) * | 2008-02-28 | 2016-03-15 | University Of Notre Dame | Metastasis inhibition preparations and methods |
| JPWO2010030002A1 (ja) | 2008-09-12 | 2012-02-02 | 国立大学法人三重大学 | 外来性gitrリガンド発現細胞 |
| US20110206736A1 (en) * | 2008-09-23 | 2011-08-25 | Thomas Jefferson University | Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same |
| EP2327764B1 (en) | 2009-11-30 | 2011-12-28 | United Cancer Research Institute | New clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer |
| PE20151921A1 (es) | 2013-03-14 | 2015-12-26 | Icahn School Med Mount Sinai | Virus de la enfermedad de newcastle y usos de los mismos |
| AU2015222685A1 (en) | 2014-02-27 | 2016-09-08 | Viralytics Limited | Combination method for treatment of cancer |
| JOP20190256A1 (ar) | 2017-05-12 | 2019-10-28 | Icahn School Med Mount Sinai | فيروسات داء نيوكاسل واستخداماتها |
| EP3837277A4 (en) | 2018-08-17 | 2022-05-11 | Icahn School of Medicine at Mount Sinai | RECOMBINANT NEWCASTLE DISEASE VIRUSES AND THEIR USES IN THE PREVENTION OF RSV DISEASE OR HUMAN METAPNEUMOVIRUS INFECTION |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2918927A1 (de) * | 1979-05-10 | 1980-11-20 | Hans Prof Dr Limburg | Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung |
| DE3432714A1 (de) * | 1984-09-06 | 1986-04-24 | Behringwerke Ag, 3550 Marburg | Tumortherapeutikum und verfahren zu seiner herstellung |
| HU197517B (en) * | 1984-07-30 | 1989-04-28 | Laszlo Csatary | Process for production of terapeutical composition applicable against virus infection |
-
1988
- 1988-03-01 DE DE3806565A patent/DE3806565A1/de active Granted
-
1989
- 1989-02-27 AU AU31889/89A patent/AU3188989A/en not_active Abandoned
- 1989-02-27 KR KR1019890702004A patent/KR900700130A/ko not_active Withdrawn
- 1989-02-27 US US07/449,851 patent/US5273745A/en not_active Expired - Fee Related
- 1989-02-27 JP JP1502563A patent/JPH02504034A/ja active Pending
- 1989-02-27 ES ES89103480T patent/ES2042828T3/es not_active Expired - Lifetime
- 1989-02-27 AT AT89103480T patent/ATE90877T1/de active
- 1989-02-27 DE DE8989103480T patent/DE58904760D1/de not_active Expired - Fee Related
- 1989-02-27 EP EP19890103480 patent/EP0331102B1/de not_active Expired - Lifetime
- 1989-02-27 WO PCT/EP1989/000186 patent/WO1989007946A1/de not_active Ceased
- 1989-10-31 DK DK541889A patent/DK541889D0/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2042828T3 (es) | 1993-12-16 |
| ATE90877T1 (de) | 1993-07-15 |
| DE3806565A1 (de) | 1989-09-14 |
| DE58904760D1 (de) | 1993-07-29 |
| DK541889A (da) | 1989-10-31 |
| WO1989007946A1 (fr) | 1989-09-08 |
| AU3188989A (en) | 1989-09-22 |
| DE3806565C2 (cg-RX-API-DMAC7.html) | 1991-04-25 |
| EP0331102A1 (de) | 1989-09-06 |
| US5273745A (en) | 1993-12-28 |
| DK541889D0 (da) | 1989-10-31 |
| EP0331102B1 (de) | 1993-06-23 |
| JPH02504034A (ja) | 1990-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE58904760D1 (de) | Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen. | |
| ATE203421T1 (de) | Keime von kobalt-palladium zur thermischen behandlung von tumoren | |
| ES2177964T3 (es) | Procedimiento de produccion de celulas t activadas marcadas especificas de tumores y su uso para el tratamiento de tumores. | |
| IL98957A0 (en) | Immunotherapy with interleukin-7 | |
| BR0206985A (pt) | Anticorpos modificados e métodos de uso | |
| AU584864B2 (en) | Method of culturing freeze-dried microorganisms | |
| UA42089C2 (uk) | Протигрипозна вакцина на основі поверхневого антигену, спосіб її виробництва | |
| DK0781092T3 (da) | Nucleinsyre som koder for adenovirus E1A-polypeptid til sensibilisering af tumorceller for kemoterapi eller bestråling | |
| RU94022017A (ru) | Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды | |
| KR960700746A (ko) | 헬리코박터 피롤리 관련 위십이지장 질환의 치료 방법(treatment of h. pylori associated gastroduodenal disease) | |
| DE68921979D1 (de) | Antikörper für die antilymphozyten-antikörpertherapie. | |
| Pollard et al. | Radiation action on DNA in bacteria: Effect of oxygen | |
| DK0889969T3 (da) | Rekombinante adenovirale til genterapi af humane tumorer | |
| GB1508878A (en) | Hepatitis a antigen | |
| ES8707565A1 (es) | Un procedimiento para producir un anticuerpo monoclonal | |
| AR015237A1 (es) | Una composicion de membranas celulares tumorales modificadas con hapteno, metodo para obtenerlas y su uso. | |
| ES8604774A1 (es) | Procedimiento de preparar agentes cosmeticos para el trata- miento de la piel | |
| AU1256495A (en) | Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor | |
| EP0248217A3 (en) | Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor | |
| SE8201128L (sv) | Forfarande for reproduktion av virulent treponema pallidum i vevnadsk ultur | |
| Gerweck et al. | The lack of correlation between heat and radiation sensitivity in mammalian cells | |
| ES550089A0 (es) | Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus. | |
| ES2047946T3 (es) | Metodos de cultivos celulares para producir proteina c activada. | |
| DE69636456D1 (de) | In-vitro verpackung von adeno-assozierten virus dns | |
| SU604554A1 (ru) | Способ пластики красной каймы губ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19891031 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |